Renaissance Technologies (RenTech)'s OBIO Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 70,900 shares of Orchestra BioMed Holdings, Inc. (OBIO) worth $301,325, representing 0.00% of the portfolio. First purchased in 2023-Q2, this short-term holding has been held for 6 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in OBIO for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 211,108 shares. Largest reduction occurred in Q4 2025, reducing 229,208 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Orchestra BioMed Holdings (OBIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Orchestra BioMed Holdings (OBIO) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -80,400 | Reduce 53.14% | 70,900 | $4.25 |
| Q4 2025 | -229,208 | Reduce 60.24% | 151,300 | $4.15 |
| Q3 2025 | +211,108 | Add 124.62% | 380,508 | $2.48 |
| Q2 2025 | +169,400 | New Buy | 169,400 | $2.68 |
| Q3 2023 | -12,600 | Sold Out | 0 | $0.00 |
| Q2 2023 | +12,600 | New Buy | 12,600 | $0.01 |
Renaissance Technologies (RenTech)'s Orchestra BioMed Holdings Investment FAQs
Renaissance Technologies (RenTech) first purchased Orchestra BioMed Holdings, Inc. (OBIO) in Q2 2023, acquiring 12,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Orchestra BioMed Holdings, Inc. (OBIO) for 6 quarters since Q2 2023.
Renaissance Technologies (RenTech)'s largest addition to Orchestra BioMed Holdings, Inc. (OBIO) was in Q3 2025, adding 380,508 shares worth $943,660.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 70,900 shares of Orchestra BioMed Holdings, Inc. (OBIO), valued at approximately $301,325.
As of the Q1 2026 filing, Orchestra BioMed Holdings, Inc. (OBIO) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Orchestra BioMed Holdings, Inc. (OBIO) was 380,508 shares, as reported at the end of Q3 2025.